Inhibitory Effects of Ninety Nine Korean Plants on Human Immunodeficiency Virus Type 1 Pretense Activity |
Park, Jong-Cheol
(Department of Oriental Medicine Resources)
Hur, Jong-Moon (Department of Oriental Medicine Resources) Park, Ju-Gwon (Department of Oriental Medicine Resources) Hyun, Kyu-Hawn (Department of Resources Plants, Sunchon National University) Lee, Kab-Yeon (Sobu Forest Experiment Station, Korea Forest Genetics Research Institute) Hirotsugu Miyashiro (Institute of Natural Medicine, Toyama Medical and Pharmaceutical University) Masao Hattori (Institute of Natural Medicine, Toyama Medical and Pharmaceutical University) |
1 | Kusumoto IT, Nakabayashi T, Kida H, Miyashiro H, Hattori M, Namba T, Shimotohno K.1995. Screening various plants extacts used in Ayurvedic medicine for inhibitory effects on human immunodeficiency virus type 1 protease. Phytother Res 9: 180-184 DOI ScienceOn |
2 | Shen Y, Ye W, Zhao S, Shu Y, Wataya M, Kakiuchi N, Hattori M, Matsuura K, Namba T. 1988. Isolation of two saponins from Anemone flaccida and their effects on reverse transcriptase. Shoyakugaku Zasshi 42: 35-40 |
3 | El-Mekkawy S, Meselhy RM, Kusumoto IT, Kadota S, Hattori M, Namba T. 1995. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus reverse transcriptase. Chem Pharm Bull 43: 641-648 DOI ScienceOn |
4 | Kusumoto IT, Kakiuchi N, Hattori M, Namba T, Sutardjo S, Shimotohno K. 1992. Screening of some Indonesian medicinal plants for inhibitory effects on HIV-1 protease. Shoyakugaku Zasshi 46: 190-193 |
5 | Lim YA, Kida H, Miyaji M, Kusumoto IT, Miyashiro H, Hattori M, Shimotohno K, Gupta MP, Correa M. 1997. Inhibitory effects of some Panamanian plants on human immunodeficiency viral reverse transcriptase and protease. J Trad Med 14: 54-58 |
6 | Katoh I, Ikawa Y, Yoshinaka Y. 1989. Retrovirus protease characterized as a dimeric aspartic proteinase. J Virol 63: 2226-2232 |
7 | Robert NA. 1988. Rational design of peptide-based HIV protease inhibitors. Science 247: 358-361 |
8 | Kohl NE, Emini EA, Schiief WA. 1988. Active human im-munodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci USA 85: 4686-4690 DOI ScienceOn |
9 | Larder BA, Kemp SD. 1989. Multiple mutations in HIV-1 reverse transcriptase confer high level resistance to zidovudine (AZT). Science 246: 1155-1158 DOI |
10 | Fukuyama Y, Minami H, Yamamoto I, Kodama M, Kawazu K. 1998. Neouvibsanins H and I, novel diterpenes from Viburnum awabuki. Chem Pharm Bull 46: 545-547 DOI ScienceOn |
11 | Fukuyama Y, Minami H, Ichikawa R, Takeuchi K, Kodama M. 1996. Hydroperoxylated quaiane-type sesquitrpenes from Viburnum awabuki. Phytochem 42: 741-746 DOI ScienceOn |
12 | Kagawa M, Minami H, Nakahara M, Takahashi H, Takaoka S, Fukuyama Y. 1998. Oleanane-type triterpenes from Viburnum awabuki. Phytochem 47: 1337-1341 DOI ScienceOn |
13 | Huff JR. 1991. HIV-1 protease : a novel chemotherapeutic target for AIDS. J Med Chem 34: 2305-2314 DOI |
14 | Pratt R. 1995. HIV & AIDS -A strategy for nursing care. 4th ed. Edward Arnold, London. p 11 |
15 | Meek TD, Lambert DM, Metcalf BW, Petterway SR, Dreyer GB. 1990. HIV-1 protease as a target for potential anti-AIDS drugs. In Design of anti-AIDS drugs. DeClercq E, ed. Elsevier Science Publishers BV, The Netherlands |
16 | Mous J, Heimer EP, Le Grice SFJ. 1988. Processing protease and reverse transcriptase from human immunodeficiency virus type 1 polyprotein in Escherichia coli. J Virol 62: 1433-1444 |